Company Profile - WuXi Biologics Cayman Inc

Introduction

WuXi Biologics Cayman Inc (Wuxi Biologics) provides solutions to discover, develop and manufacture biologics. The company offers protein generation, assay development, antibody generation, screening, characterization and optimization, regulatory affairs and testing services. It utilizes WuXiBody bispecific antibody platform to discover antibodies, CRISPR gene editing technology for improving cell growth and productivity and microbial expression and a fermentation platform to manufacture new proteins and plasmids. Wuxi Biologics also provides cell culture development and manufacturing, scale-out manufacturing and other services through its platform technology. The company operates production plants in China, Singapore, Ireland, Germany and the US. Wuxi Bio is headquartered in Wuxi, Jiangsu, China.